Navigation Links
New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Date:4/9/2008

Emerging Agent GlaxoSmithKline's Rezonic Demonstrating Efficacy for Delayed Chemotherapy-Induced Nausea and Vomiting, According to a New Report from

Decision Resources

WALTHAM, Mass., April 9, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the regimen of Merck's Emend for Injection/Ivemend combined with 5-HT3 RA, is positioned to earn gold-standard status in the treatment of chemotherapy-induced nausea and vomiting by 2011. The regimen of Emend for Injection/Ivemend and 5-HT3 RA offers robust efficacy and key advantages in delivery as a result of its availability in a single-dose IV formulation that is more convenient than the three-consecutive-day-dosing schedule of Merck's Emend, the current gold standard.

The new report entitled Chemotherapy-Induced Nausea and Vomiting: Physician Satisfaction with Inexpensive Antiemetics Sets High Hurdles for Reformulations and Emerging Agents, also finds that GlaxoSmithKline's Rezonic, launching in 2009 as the second-to-market NK1 RA, is positioned as the only emerging agent, compared with Emend, with the potential to demonstrate better control over delayed chemotherapy-induced nausea and vomiting in patients taking highly emetogenic chemotherapy. Preliminary data from clinical trials show that the addition of oral Rezonic to GlaxoSmithKline's Zofran and Merck/Banyu's Decadron result in an 86 percent of patients with no emetic episodes and do not require rescue therapy compared with Emend's 68 percent; however, more data is needed to confirm the effect on delayed chemotherapy-induced nausea and vomiting. Additionally, unless Rezonic shows extraordinary efficacy or is priced much lower than currently available NK1 antagonists, it is not expected to gain more patient share than the Emend franchise owing to Emend's first-to-market status in the injectable NK1 antagonist class.

<
'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
5. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
6. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
7. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Stem Cell Therapy to Skyrocket by 2017
10. Team demos safety of RNA therapy
11. First European IGRT School Takes Place for Radiotherapy Practitioners in UK

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , NEW YORK, Nov. 25 Report...port is available in its catalogue: ,, Brazil ...,, http://www.reportlinker.com/p0165503/Brazil...html ,, Brazil Bioethanol Market Analysis and ... provides detailed analysis and forecasts of the g...
(Date:11/24/2009)... The New York investment bank KTA...NEU) has agreed an AU$6.7 mil convertible note pri... The private placement was arranged by KTA Capital.... , New York (PRWEB) Nove...nt bank KTA Capital, LLC ("KTA Capital")...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)..., SEATTLE, Nov. 24 Blue Marble E...he Odessa Public Development Authority (OPDA) were... Community Economic Revitalization Board (CERB) in...te,s first specialty biochemical biorefinery in Li...gnificantly speed the development of our biorefine...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...itigation experience, NEW YORK, July 7 McKool Sm... property and commercial litigation trial firms, i...of accomplished litigation,attorney Gayle Rosenste...cipal and brings broad experience,representing com...perty,disputes, complex business litigation and se...
...logical,Technologies, Inc. (NTI(R)) (Nasdaq: NTII...t and chief executive officer (CEO), has announced...mpany expects Mr. Freiman to,continue to serve on ...ve,officer of Syntex Corporation of Palo Alto, Cal...of service to the company.,"Paul,s strong leadersh...
...all/ - Angiotech Pharmaceuticals,Inc. ("Angiotech"...harmaceutical and medical device company, today an... the outstanding notes listed below (the "Notes"),...hase price (including,accrued and unpaid interest ...e below) of $165 million for all Notes purchased. ...
Other Biology Technology:McKool Smith Adds Noted Litigator in New York 2Neurobiological Technologies' CEO to Retire on December 31, 2008 2Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 2Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 3Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 4Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 5Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 6Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 7Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 8
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife Cons...vealing that the last remaining population of Sibe...to the rising tide of poaching and habitat loss. ,...m Russian officials of what needs to be done to pr... cat. , The report was released by ...
(Date:11/24/2009)...s available in Spanish . , The presence of ... inflammatory substances in the blood, hinders the...a research project of the University of Navarra co...t the School of Pharmacy. , The project, entitle...on to the control of body weight and inflammation,...
(Date:11/23/2009)...mber 23, 2009 - The time of day matters to forest ...er produced by a research team led by Professor Ma...s vice-principal for research and colleagues in th.... George campus. , Capitalizing on their previ...the research team examined how poplar trees use th...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 1NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 2VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification 54896 1VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification 54896 2VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification 54896 3MSU scientists 3A Progesterone leads to inflammation 54891 1MSU scientists 3A Progesterone leads to inflammation 54891 2
...pivotal in lifting depression has been discovered ...nal Institutes of Health,s National Institute of M...otein, called p11, display depression-like behavio...if they have been treated with antidepressants," e...ersity neuroscientist who received the 2000 Nobel ...
...bacterium is becoming more prevalent in many inten...b. 1 issue of Clinical Infectious Diseases, now av...ccus aureus (MRSA) is responsible for a variety of...pital. Skin infections are the most common, but MR...igestive tract. The emergence of MRSA and other dr...
...ociated with Alzheimer,s disease in the brain of t...riguing link between neuronal death and proteins p...re reported by Vik Khurana, Mel Feany, and colleag...ical School, and the Burnham Institute. , Neurons...fore perplexing that in Alzheimer,s disease, and o...
Other Biology News:Nobelist discovers antidepressant protein in mouse brain 2Nobelist discovers antidepressant protein in mouse brain 3Drug-resistant bacteria patterns in intensive care units changing nationally 2
Extensor Control & Template from ABgene
Robotic MBS Thermal Cycler 0.2 ml from Thermo Scientific
Mango-Taq DNA Polymerase from Bioline
Biolase Red DNA Polymerase from Bioline
Biology Products: